Dr. Catherine Victoria Kulick, MD

Dr. Kulick practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Kulick's NPI, 1235626904, was assigned on April 18, 2018. Dr. Kulick holds Pennsylvania license MD476751.

Dr. Kulick's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Kulick's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Kulick is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Kulick to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kulick practices, 6 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Kulick's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Kulick is licensed in Pennsylvania.

CMS data shows 424 Medicare services from Dr. Kulick across 8 procedure codes in 2024, for 160 Medicare patients. Medicare paid $23,093 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Kulick in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kulick's median patient age at 45, with 53% women.

In 2024, Dr. Kulick wrote 228 Medicare Part D claims for 58 patients. 93% of them were for generic drugs. CMS names the drug for 159 of them, across 7 drugs with 11 or more claims each, at $13,526 in total drug cost. In 2023, CMS named 98 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kulick for performance year 2024, reported as part of a group. Dr. Kulick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kulick as offering telehealth.

Dmand AI links 7 papers to Dr. Kulick, published from 2014 to 2018. 2014 was the busiest year, with 3. The most frequent topics are Anticonvulsants, Rats, Sprague-Dawley and Animals, Newborn. Dr. Kulick has published most often in Epilepsy Behav. Dr. Kulick's most frequent co-author is Melissa Jill Nirenberg, MD, PhD.

CMS Open Payments shows 12 general payments to Dr. Kulick from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 98% of the total. DIXI Medical USA Corp paid the most, $852.